Vectra Polaris microscope imaging system
Vectra Polaris microscope imaging system
批准号:
10175807
负责人:
Mercedes Gonzalez-Juarrero
金额:
$45.18万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2022-08-31
关键词:
AffectBiologicalBiological MarkersCell CommunicationColoradoComputer softwareCore FacilityDevelopmentDiseaseFlow CytometryFluorescenceFormalinFoundationsFundingGenus MycobacteriumImageImaging technologyImmune responseImmunofluorescence ImmunologicImmunohistochemistryImmunologic MarkersLaboratory ResearchLightingMachine LearningMicroscopeMicroscopicMicroscopyMissionNatureNoisePhotobleachingPre-Clinical ModelResearchResearch PersonnelSafetySamplingScanningSignal TransductionSlideSpecimenSpeedStainsStructureSystemTechnologyTimeTissue SampleTissuesTrainingUnited States National Institutes of HealthUniversitiesVaccinesbasechemotherapydigitalimaging systemimprovedliquid crystal polymermicroscopic imagingmycobacterialoperationquantitative imagingspatial relationshipuser-friendlyvaccine candidate
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
This proposal seeks funding for a Vectra® Polaris™ Automated Quantitative Imaging System (Polaris™), a state-
of-the-art multispectral imaging microscope to serve multiple NIH-supported projects within the Mycobacteria
Research Laboratories (MRL) at Colorado State University (CSU). Our collective mission is to develop effective
chemotherapies and vaccines for mycobacterial diseases affecting millions worldwide. The biological activity and
safety profile of candidate vaccines and treatments can only be fully understood through characterizing the host
immune response, primarily by evaluating large networks of immune biomarkers through flow cytometry and
immunohistochemistry. MRL researchers are seeking to visualize the spatial expression of immune biomarkers by
multiplex staining of intact tissue samples obtained from preclinical models of mycobacterial diseases. Until now,
microscopic analysis of biomarkers through confocal and traditional immunofluorescence was drastically limited by
autofluorescence in tissue (especially in formalin fixed and diseased tissue) and low signal-to-noise ratios. The
Polaris™ system has a unique set of microscopic capabilities that combined with the inForm® workstation allows
simultaneous identification and quantification of multiple targets and their spatial relationships in tissue sections
and microarrays. A critical aspect of the PolarisTM multispectral technology is the ability to readily distinguish
autofluorescence from positive biomarker signal, improving the signal-to-noise ratio substantially. This allows for a
more sensitive and accurate analysis of samples and enables true cell-to-cell interactions to be revealed. The
system is user-friendly, and its automated scanning system allows for high speed digital and whole-slide scanning
between 10-40x in brightfield or fluorescence. The nature of the illumination system significantly decreases
deleterious effects such as photobleaching and photodamage, and thus specimens can be imaged for longer
periods of time than with, for example, a confocal microscope. Furthermore, the advanced machine-learning based
approaches of the included software automatically segment and quantitate tissue structures. The Polaris™ system
will be incorporated into our existing microscopy core facility in order to expand access to trainees and other
research groups at CSU and in Northern Colorado, while prioritizing access for the major users. Incorporation into
the foundational core will sustain long term operation and provide consistent oversight and training. In summary,
this state-of-the-art imaging technology is of critical importance to development of chemotherapies and vaccines
by the MRL and will add value to multiple other NIH-supported projects at CSU.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhaled tigecycline therapy for pulmonary M. abscessus infections
-
批准号:10312329
-
项目类别:
-
资助金额:$83.64万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
-
批准号:10437923
-
项目类别:
-
资助金额:$79.41万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
-
批准号:10490882
-
项目类别:
-
资助金额:$63.76万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
-
批准号:10685409
-
项目类别:
-
资助金额:$63.76万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
-
批准号:10387219
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
-
批准号:10626051
-
项目类别:
-
资助金额:$69.12万
-
财政年份:2021
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Minipigs as animal model for infant TB and vaccine efficacy
-
批准号:8810222
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2014
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
siRNA-nanoparticles host targeted immunotherapy for tuberculosis
-
批准号:8638299
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2014
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Minipigs as animal model for infant TB and vaccine efficacy
-
批准号:8684285
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2014
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Host targeted immunotherapy for TB treatment
-
批准号:8487363
-
项目类别:
-
资助金额:$19.22万
-
财政年份:2012
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Host targeted immunotherapy for TB treatment
-
批准号:8391404
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2012
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
Zeiss LSM 510 Laser Scanning Microscope
-
批准号:7217125
-
项目类别:
-
资助金额:$43.74万
-
财政年份:2007
-
负责人:Mercedes Gonzalez-Juarrero
-
依托单位:
海外基金